Intensive Monitoring of Post-surgery Pain in Major Ambulatory Surgery

November 28, 2025 updated by: Consorci Sanitari del Maresme

Seguimiento Intensivo Del Dolor Postoperatorio en cirugía Mayor Ambulatoria: Estudio de Viabilidad y Resultados

Moderate to severe acute postoperative pain (APP) during part of the postoperative period is a barrier that hinders the central objective of perioperative medicine, which is to achieve an optimal postoperative recovery process. Despite advances in perioperative medicine, a large proportion of post-operative patients continue to suffer from moderate to severe APS during many of the days of their convalescence. This poor control of APS, in addition to causing suffering and exposing the patient to an increased risk of complications, could impair the quality of post-surgical recovery , according to some authors. We therefore consider it to be of utmost interest in our field to corroborate whether the implementation of measures to better control DAP is related to a better quality of post-surgical recovery.

Currently, the growing trend to take into account the perspective of patients in their care has prompted the development of various patient-centred measurement tools that, among other aspects, assess the quality of post-surgical recovery. Several scales have been designed. The most widely used are the QoR-40, QoR-9 and QoR-15 scales. The latter, with a range of 0 to 150, was developed to simplify assessment, especially in telephone follow-ups, and has a reliability similar to its predecessor, the QoR-40.

Study Overview

Study Type

Interventional

Enrollment (Actual)

280

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Mataró, Barcelona, Spain, 08304
        • Consorci Sanitari Del Maresme

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients ≥ 18 years old.
  • ASA I - III.
  • Scheduled for the surgeries: Laparoscopic or open inguinal hernia repairs, Laparoscopic cholecystectomies, Haemorrhoid surgeries, Knee arthroscopies, Shoulder arthroscopies.
  • Willingness to be contacted by telephone during the duration of the study.
  • Informed written consent to participate in this study.

Exclusion Criteria:

  • Lack of proficiency in Spanish.
  • Undergoing study or follow-up for moderate to severe cognitive impairment.
  • Pregnant or breastfeeding patients.
  • Patients on major opioid medication.
  • Patients with a history of dependence/abuse of alcohol or illicit drugs at present.
  • Patients under active follow-up by the chronic pain unit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard monitoring group
Routine follow-up (telephone call on the morning after surgery)
Routine follow-up (telephone call on the morning after surgery).
Experimental: Intensive monitoring group
Routine follow-up (telephone call on the morning after surgery) and Intensive follow-up of acute post-surgery pain.
Routine follow-up (telephone call on the morning after surgery) and Intensive follow-up of acute post-surgery pain (telephone call every day since pain resolution).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Recovery
Time Frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Quality of Recovery (QoR15 test)
Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction of pain control
Time Frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
A 4-level Likert scale will be used according to the patient's criteria: dissatisfied, slightly dissatisfied, fairly satisfied, completely satisfied.
Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Adherence to prescribed analgesic treatment
Time Frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
4-level Likert scale according to the patient's criteria: no adherence, low adherence, moderate adherence, and total adherence.
Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Pain Control by Visual Analogic Scale
Time Frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Visual Analogic Scale of pain. Range values: 0 (minium pain) thru 10 (maximum pain)
Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2025

Primary Completion (Actual)

August 5, 2025

Study Completion (Actual)

August 15, 2025

Study Registration Dates

First Submitted

November 19, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Estimated)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

November 28, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cholecystectomy, Laparoscopic

Clinical Trials on Standard monitoring group

Subscribe